Skip to main content
. 2016 Sep 1;10(9):EC05–EC09. doi: 10.7860/JCDR/2016/20475.8539

[Table/Fig-5]:

Comparison of clinico-pathological features in basal and non basal TNBC.

Parameters Basal Number
of cases (%)
Non-basal
Number of
cases (%)
p-value
Age: Mean(SD) 47.29(46.17) 12.21 (10.21) 0.78
Age
< 40 years
> 40 years

8(24)
26(76)

2(17)
10(83)

0.93
Family history
Present
3(12) --- 0.81
Size
<1cm
1-2cm
>2cm

---
14(52)
13(48)

2(25)
4(50)
2(25)


0.023
Lymph node involvement 28(80) 9(75) 0.644
Tubules
No tubules
<10%
10-75%
>75%

7(20)
23(66)
5(14)
---

5(42)
5(42)
2(16)
---


0.28
Nuclear pleomorphism
Moderate
Marked

28(80)
7(20)

11(92)
1(8)

0.63
Shape of cells
Polygonal
Spindle

34(97)
1(3)

12(100)
---

1.00
Chromatin
Hyperchromatic
Vesicular
Hyperchromatic and vesicular

12(34)
10(29)
13(37)

4(33)
4(33)
4(33)


0.95
Nucleoli
Inconspicuous/absent
Present
Prominent

2(6)
11(31)
22(63)

1(8)
4(34)
7(58)


0.93
Cytoplasmic amount
Moderate
Abundant

33(94)
2(6)

8(67)
4(33)

0.04
Mitotic rate
<10
10-40
>40

6(17)
18(51)
11(32)

5(42)
7(58)
---


0.09
Squamous metaplasia
Present

3(8.5)

---

0.72
Other metaplasias
Present
1(3) --- 1.00
Necrosis
Present
28(80) 6(50) 0.10
Central acellular sclerosis
Present
5(14) 1(8) 0.97
DCIS
Present
13(37) 3(25) 0.68
Lymphocytic infiltrate
Absent
Mild
Moderate
Marked
---
20(57)
11(31)
4(12)
1(8)
6(50)
3(25)
2(17)
0.35
Lymphovascular invasion
Present
25(71) 9(75) 1.00
WHO subtype
Invasive ductal carcinoma
Others

33(94)
2(6)

11(92)
1(8)
1.00
Histological grade
Grade II
Grade III
16(46)
19(54)
5(50)
5(50)

0.55
Ishikawa subtypes
Type A
Type B
Type C
Type D
6(17)
6(17)
22(63)
1(3)
1(8)
1(8)
9(76)
1(8)
0.62